SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.170+2.2%9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: hpgrant who wrote (10273)5/15/2018 12:23:31 PM
From: HardToFind  Read Replies (1) of 12873
 
Dr. Seymour has stated that he was resigning for personal reasons and to make room for a pharmaceutical industry executive with experience in drug development through regulatory stages.
Sort of sounds like a non-denial denial. Yes, he did state that.

It doesn't exactly explain why the $10K expense reimbursement (legal expenses?). It doesn't explain why Seymour was immediately removed from the BOD upon his resigning from his full-time position and moving to an emeritus role. It still seems unusual for options to be granted that vest after Seymour having left the company, as well as his salary coming in bimonthly instead of a lump sum upon departure.

Perhaps the non-disparagement clause goes both ways.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News